Skip to main content

NORGES BANK

Bank

Position in EXEL — Exelixis, Inc.

CIK 1374170 OSLO, Q8

Position in EXEL

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$146,301,199
+$39,841,548 QoQ
Shares Held
2,688,866
+10.7% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#22
of 756 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. EXEL ranks #14 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EXEL

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $146,301,199 2,688,866
2025-12-31 $106,459,651 2,428,922
2025-06-30 $122,113,060 2,770,260
2025-03-31 $105,753,758 2,864,403
2024-12-31 $94,867,371 2,848,870
2024-09-30 $73,364,360 2,827,143
2024-06-30 $62,673,458 2,789,206
2024-03-31 $78,309,806 3,300,034
2023-12-31 $73,448,911 3,061,647
2023-09-30 $64,251,782 2,940,585
2023-06-30 $54,304,485 2,841,679
2023-03-31 $53,861,546 2,774,938
2022-12-31 $50,953,257 3,176,637
2022-09-30 $45,833,878 2,923,079
2022-06-30 $58,611,069 2,815,133
2022-03-31 $64,516,122 2,845,881
2021-12-31 $55,442,581 3,032,964
2021-09-30 $60,338,992 2,854,257
2021-06-30 $52,004,562 2,854,257
2021-03-31 $65,210,869 2,886,714
2020-12-31 $60,911,065 3,034,931
2020-09-30 $76,014,561 3,108,980
2020-06-30 $71,467,726 3,010,435
2020-03-31 $50,892,452 2,955,427